Halozyme Reports Significant Recent Achievements And Second Quarter 2020 Results

Go back to Halozyme Reports Significant Recent Achievements And Second Quarter 2020 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 104.89 +1.89 (1.83%)
Previous Close $103.00    52 Week High $18.39 
Open $102.95    52 Week Low $6.96 
Day High $105.11    P/E N/A 
Day Low $102.39    EPS $-0.58 
Volume 1,954,549